{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:39:08Z","timestamp":1790797148538,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T00:00:00Z","timestamp":1608768000000},"content-version":"am","delay-in-days":389,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.euroneuro.2019.10.012","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T18:51:45Z","timestamp":1574448705000},"page":"1419-1432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Ethosuximide improves chronic pain-induced anxiety- and depression-like behaviors"],"prefix":"10.1016","volume":"29","author":[{"given":"Nicolas","family":"Kerckhove","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludivine","family":"Boudieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Ourties","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Bourdier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Daulhac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Eschalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2019.10.012_bib0001","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbr.2019.02.006","article-title":"PINK1 deficiency is associated with increased deficits of adult hippocampal neurogenesis and lowers the threshold for stress-induced depression in mice","volume":"363","author":"Agnihotri","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0002","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pain.2009.03.024","article-title":"Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study","volume":"144","author":"Attal","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0003","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jhsa.2009.07.002","article-title":"Effect of upper extremity nerve damage on activity participation, pain, depression, and quality of life","volume":"34","author":"Bailey","year":"2009","journal-title":"J. Hand Surg."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0004","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10549-016-3939-0","article-title":"Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk","volume":"159","author":"Bao","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejphar.2005.08.017","article-title":"The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil","volume":"521","author":"Barton","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0006","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neulet.2017.08.019","article-title":"A standardization of the novelty-suppressed feeding test protocol in rats","volume":"658","author":"Blasco-Serra","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0007","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00442264","article-title":"A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety","volume":"97","author":"Bodnoff","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0008","doi-asserted-by":"crossref","first-page":"559","DOI":"10.36076\/ppj.2011\/14\/559","article-title":"Predictors for persistent neuropathic pain \u2013 a Delphi survey","volume":"14","author":"Boogaard","year":"2011","journal-title":"Pain Phys."},{"issue":"Suppl 1","key":"10.1016\/j.euroneuro.2019.10.012_bib0009","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/j.pain.0000000000000469","article-title":"T-type calcium channels in neuropathic pain","volume":"157","author":"Bourinet","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0010","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nrrheum.2014.123","article-title":"Adverse reactions to biologic agents and their medical management","volume":"10","author":"Boyman","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0011","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FBP.0b013e3280141375","article-title":"Effects of intrathecal injection of T-type calcium channel blockers in the rat formalin test","volume":"18","author":"Cheng","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0013","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1601-183X.2006.00268.x","article-title":"Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels","volume":"6","author":"Choi","year":"2007","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0014","first-page":"257","article-title":"Scolopendra pharmacopuncture ameliorates behavioral despair in mice stressed by chronic restraint","volume":"20","author":"Choi","year":"2017","journal-title":"J. Pharmacopunct."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0015","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s11916-012-0318-3","article-title":"Temperament, character, and personality disorders in chronic pain","volume":"17","author":"Conrad","year":"2013","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0016","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1476-5381.1990.tb14095.x","article-title":"Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: calcium current reduction","volume":"100","author":"Coulter","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0017","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pain.2007.01.022","article-title":"Mental disorders among persons with chronic back or neck pain: results from the World Mental Health Surveys","volume":"129","author":"Demyttenaere","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0018","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-3959(03)00177-5","article-title":"Reversal of experimental neuropathic pain by T-type calcium channel blockers","volume":"105","author":"Dogrul","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0019","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1111\/bph.14063","article-title":"Characterization of a rat model of bortezomib-induced painful neuropathy","volume":"174","author":"Duggett","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00002508-199106000-00004","article-title":"Clinical aspects of depression in chronic pain patients","volume":"7","author":"Dworkin","year":"1991","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0021","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/ebeh.2000.0143","article-title":"Lamotrigine monotherapy improves depressive symptoms in epilepsy: a double-blind comparison with valproate","volume":"2","author":"Edwards","year":"2001","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0022","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nrrheum.2011.2","article-title":"Pain, catastrophizing, and depression in the rheumatic diseases","volume":"7","author":"Edwards","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0023","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.yebeh.2006.09.008","article-title":"Effect of lamotrigine on depressive symptoms in adult patients with epilepsy","volume":"10","author":"Ettinger","year":"2007","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0024","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pain.2004.01.029","article-title":"Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy","volume":"109","author":"Flatters","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0026","first-page":"758","article-title":"A-fibers mediate cold hyperalgesia in patients with oxaliplatin-induced neuropathy","volume":"18","author":"Forstenpointner","year":"2018","journal-title":"Pain Pract. Off. J. World Inst. Pain"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0027","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pain.2012.10.023","article-title":"State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects","volume":"154","author":"Francois","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0028","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fnbeh.2014.00092","article-title":"T-type calcium channel Cav3.2 deficient mice show elevated anxiety, impaired memory and reduced sensitivity to psychostimulants","volume":"8","author":"Gangarossa","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0029","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","year":"2015","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0030","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1186\/1471-2458-11-770","article-title":"Pain as a global public health priority","volume":"11","author":"Goldberg","year":"2011","journal-title":"BMC Publ. Health"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0031","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.semarthrit.2008.11.005","article-title":"The interface of pain and mood disturbances in the rheumatic diseases","volume":"40","author":"Goldenberg","year":"2010","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0032","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1399-6576.2007.01486.x","article-title":"Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey","volume":"52","author":"Gustorff","year":"2008","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0033","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/ejp.550","article-title":"Antinociceptive activity of the new triple reuptake inhibitor NS18283 in a mouse model of chemotherapy-induced neuropathic pain","volume":"19","author":"Hache","year":"2015","journal-title":"Eur. J. Pain Lond. Engl."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0034","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejphar.2011.11.026","article-title":"Ethosuximide reduces allodynia and hyperalgesia and potentiates morphine effects in the chronic constriction injury model of neuropathic pain","volume":"674","author":"Hamidi","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0035","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Hershman","year":"2014","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0036","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/rheumatology\/kep170","article-title":"Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic","volume":"48","author":"Hider","year":"2009","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0037","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s10067-006-0407-y","article-title":"Anxiety and depression in patients with rheumatoid arthritis","volume":"26","author":"Isik","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0038","first-page":"173","article-title":"Relationship of negative affect and outcome of an opioid therapy trial among low back pain patients","volume":"13","author":"Jamison","year":"2013","journal-title":"Pain Pract. Off. J. World Inst. Pain"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib88","article-title":"Dual role of T-type calcium channels in anxiety-related behavior","author":"Kaur","year":"2019","journal-title":"J. Basic. Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0039","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1744-8069-8-7","article-title":"L type Ca2+ channel blockers prevent oxaliplatin-induced cold hyperalgesia and TRPM8 overexpression in rats","volume":"8","author":"Kawashiri","year":"2012","journal-title":"Mol. Pain"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0040","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.pain.2014.01.015","article-title":"Ca(v)3.2 calcium channels: the key protagonist in the supraspinal effect of paracetamol","volume":"155","author":"Kerckhove","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0041","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015380","article-title":"Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome \u2013 IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial","volume":"7","author":"Kerckhove","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0042","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/jgm.1473","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"12","author":"Kilkenny","year":"2010","journal-title":"J. Gene Med."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0043","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pain.2008.09.003","article-title":"Depression and changed pain perception: hints for a central disinhibition mechanism","volume":"140","author":"Klauenberg","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0044","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/art.24647","article-title":"Depression, inflammation, and pain in patients with rheumatoid arthritis","volume":"61","author":"Kojima","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0045","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/gast.2003.50054","article-title":"Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use","volume":"124","author":"Laine","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0046","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/mus.10559","article-title":"Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy","volume":"29","author":"Lehky","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000435929","article-title":"Animal models for the study of comorbid pain and psychiatric disorders","volume":"30","author":"Leite-Almeida","year":"2015","journal-title":"Mod. Trends Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0048","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.18-13-04842.1998","article-title":"On the action of the anti-absence drug ethosuximide in the rat and cat thalamus","volume":"18","author":"Leresche","year":"1998","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0049","doi-asserted-by":"crossref","first-page":"15222","DOI":"10.1073\/pnas.96.26.15222","article-title":"Thalamocortical dysrhythmia: a neurological and neuropsychiatric syndrome characterized by magnetoencephalography","volume":"96","author":"Llin\u00e1s","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0050","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/ejp.1206","article-title":"Randomized double-blind controlled study of bedtime low-dose amitriptyline in chronic neck pain","volume":"22","author":"Maarrawi","year":"2018","journal-title":"Eur. J. Pain Lond. Engl."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0051","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jpain.2007.08.002","article-title":"Associations between arthritis and a broad range of psychiatric disorders: findings from a nationally representative sample","volume":"9","author":"McWilliams","year":"2008","journal-title":"J. Pain Off. J. Am. Pain Soc."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0052","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pain.2004.06.002","article-title":"Depression and anxiety associated with three pain conditions: results from a nationally representative sample","volume":"111","author":"McWilliams","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0053","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2165\/00003495-200868110-00003","article-title":"Depressive symptoms in epilepsy: prevalence, impact, aetiology, biological correlates and effect of treatment with antiepileptic drugs","volume":"68","author":"Miller","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0054","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.neuropharm.2007.07.002","article-title":"Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety","volume":"53","author":"Munro","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0055","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neuroscience.2011.05.004","article-title":"Inhibition of T-type calcium channels and hydrogen sulfide-forming enzyme reverses paclitaxel-evoked neuropathic hyperalgesia in rats","volume":"188","author":"Okubo","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0056","article-title":"The impact of anxiety and depression on the outcomes of chronic low back pain multidisciplinary pain management-a multicenter prospective cohort study in pain clinics with one-year follow-up","author":"Oliveira","year":"2018","journal-title":"Pain Med. Malden Mass"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0057","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/j.pain.2014.09.013","article-title":"Role of the TREK2 potassium channel in cold and warm thermosensation and in pain perception","volume":"155","author":"Pereira","year":"2014","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.euroneuro.2019.10.012_bib87","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/bph.14608","article-title":"Inhibition of Cav3.2 calcium channels: A new target for colonic hypersensitivity associated with low-grade inflammation","volume":"176","author":"Picard","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0058","doi-asserted-by":"crossref","first-page":"9896","DOI":"10.1523\/JNEUROSCI.21-24-09896.2001","article-title":"Exacerbation of pain by anxiety is associated with activity in a hippocampal network","volume":"21","author":"Ploghaus","year":"2001","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0059","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0060","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1517\/14740338.2015.1056777","article-title":"Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives","volume":"14","author":"Poupon","year":"2015","journal-title":"Exp. Opin. Drug Saf."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0061","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuropharm.2018.07.026","article-title":"Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin","volume":"140","author":"Poupon","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0062","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.288.5472.1769","article-title":"Psychological and neural mechanisms of the affective dimension of pain","volume":"288","author":"Price","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0063","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/j.1532-2149.2013.00334.x","article-title":"Psychiatric co-morbidities in patients with chronic peripheral neuropathic pain: a multicentre cohort study","volume":"17","author":"Radat","year":"2013","journal-title":"Eur. J. Pain Lond. Engl."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0064","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pain.2008.08.017","article-title":"Animal models and the prediction of efficacy in clinical trials of analgesic drugs: a critical appraisal and call for uniform reporting standards","volume":"139","author":"Rice","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0065","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0091-3057(95)00138-M","article-title":"Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety","volume":"52","author":"Rodgers","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0066","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/da.20072","article-title":"The relationship between anxiety disorders and physical disorders in the U.S. National Comorbidity Survey","volume":"21","author":"Sareen","year":"2005","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0067","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1254\/jphs.13R05CP","article-title":"T-type calcium channels: functional regulation and implication in pain signaling","volume":"122","author":"Sekiguchi","year":"2013","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0068","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.neuropharm.2005.01.013","article-title":"Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats","volume":"48","author":"Shannon","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0069","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/rheumatology\/kel231","article-title":"Depression in rheumatoid arthritis\u2013underscoring the problem","volume":"45","author":"Sheehy","year":"2006","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1067\/S1526-5900(03)00781-8","article-title":"Spared nerve injury model of neuropathic pain in the mouse: a behavioral and anatomic analysis","volume":"4","author":"Shields","year":"2003","journal-title":"J. Pain Off. J. Am. Pain Soc."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0071","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0072","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1111\/bph.13906","article-title":"Recent advances in the development of T-type calcium channel blockers for pain intervention","volume":"175","author":"Snutch","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2017.06.028","article-title":"The risk of major NSAID Toxicity with Celecoxib, Ibuprofen or Naproxen: a secondary analysis of the precision randomized controlled clinical trial","author":"Solomon","year":"2017","journal-title":"Am. J. Med."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0074","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0075","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1523\/JNEUROSCI.19-06-01895.1999","article-title":"Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels","volume":"19","author":"Talley","year":"1999","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0076","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/cncr.23589","article-title":"Delayed emotional recovery after taxane-based chemotherapy","volume":"113","author":"Thornton","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0077","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1152\/jn.1998.79.1.240","article-title":"Pharmacological properties of T-type Ca2+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents","volume":"79","author":"Todorovic","year":"1998","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0078","first-page":"3307","article-title":"Oxaliplatin-induced peripheral neuropathy's effects on health-related quality of life of colorectal cancer survivors","volume":"21","author":"Tofthagen","year":"2013","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0079","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neuropharm.2017.02.020","article-title":"Effects of paclitaxel on the development of neuropathy and affective behaviors in the mouse","volume":"117","author":"Toma","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/J354v21n04_04","article-title":"Mental disorders in chronic pain patients","volume":"21","author":"Twillman","year":"2007","journal-title":"J. Pain Palliat. Care Pharmacother."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0081","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/j.pain.0000000000000404","article-title":"Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel","volume":"157","author":"Ventzel","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0082","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/ALN.0000000000000768","article-title":"Psychiatric comorbidity is associated prospectively with diminished opioid analgesia and increased opioid misuse in patients with chronic low back pain","volume":"123","author":"Wasan","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0083","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00002508-200203000-00002","article-title":"Major depression and insomnia in chronic pain","volume":"18","author":"Wilson","year":"2002","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0084","series-title":"The Burden of Musculoskeletal Conditions at the Start of the New Millennium","year":"2003"},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0085","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neubiorev.2014.08.002","article-title":"Emotional consequences of neuropathic pain: insight from preclinical studies","volume":"47","author":"Yalcin","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2019.10.012_bib0086","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tins.2016.01.006","article-title":"Neural mechanisms underlying anxiety-chronic pain interactions","volume":"39","author":"Zhuo","year":"2016","journal-title":"Trends Neurosci."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X19317249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X19317249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:53:13Z","timestamp":1760377993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X19317249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":88,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0924977X19317249"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2019.10.012","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethosuximide improves chronic pain-induced anxiety- and depression-like behaviors","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2019.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}